| 1 |
Jeff Castelli |
Amicus Therapeutics |
12 |
| 2 |
John B. Stetson, Jr. |
Lockheed Martin |
5 |
| 2 |
Hung V. Do |
Amicus Therapeutics |
5 |
| 2 |
Nicholas J. Thompson |
Comcast |
5 |
| #5 |
Mark Waldman |
Global Trademarks |
4 |
| #5 |
Mohsen N. Harandi |
ExxonMobil |
4 |
| #5 |
Hong Wu |
Bristol-Myers Squibb |
4 |
| #8 |
Michael J. Orwat |
Bristol-Myers Squibb |
3 |
| #9 |
Audris Huang |
Bristol-Myers Squibb |
2 |
| #9 |
Christopher S. Koeppen |
Ii-Vi Delaware |
2 |
| #9 |
Andrea Crocker |
Celldex Therapeutics |
2 |
| #9 |
David Weinstein |
The Meet Group |
2 |
| #9 |
John DeAndrea |
Finisar |
2 |
| #9 |
Wayne E. Childers |
Amerimas Home Products |
2 |
| #9 |
Laurie A. Kenvin |
Agios Pharmaceuticals |
2 |
| #9 |
David E. Wachob |
Antronix |
2 |
| #17 |
Eric E. Thompson |
Emhart |
1 |
| #17 |
William R. Baumbach |
Caliber Therapeutics |
1 |
| #17 |
Ruowei MO |
Novartis Ag |
1 |
| #17 |
J. Stephen Scott |
Freehold Surgical |
1 |
| #17 |
Scott A. Wadsworth |
Depuy Synthes Products |
1 |
| #17 |
Carol Hui Hu |
Bristol-Myers Squibb |
1 |
| #17 |
Jonathan Singer |
Chiral Photonics |
1 |
| #17 |
Keith Gastauer |
The Dun & Bradstreet |
1 |
| #17 |
Juan Rafael Bravo |
Antronix |
1 |
| #17 |
Stanley Pq Yavoroski |
— |
1 |
| #17 |
Thomas E. Nowakowski |
United Color Manufacturing |
1 |
| #17 |
John D. LIPANI |
— |
1 |
| #17 |
Daniel O'Malley |
Innate Tumor Immunity |
1 |
| #17 |
Michael E. Mertzman |
Bristol-Myers Squibb |
1 |
| #17 |
Ricardo De Oliveira |
Edgewell Personal Care Brands |
1 |
| #17 |
Robert H. Spencer |
Cara Therapeutics |
1 |
| #17 |
Roger de la Torre |
General Surgical Innovations |
1 |
| #17 |
Richard Nettles |
Gilead Sciences |
1 |
| #17 |
Cailan Wang |
Bristol-Myers Squibb |
1 |
| #17 |
William J. Cockayne |
Bank of America |
1 |
| #17 |
Daniel Joseph Niedziocha |
Scientific Instrument Services |
1 |
| #17 |
Dene H. Taylor |
Temptime |
1 |
| #17 |
Alicia Regueiro-Ren |
Bristol-Myers Squibb |
1 |
| #17 |
James E. Searing |
— |
1 |
| #17 |
Stuart Carlitz |
— |
1 |